Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Study reveals Real-World choices in treating complicated diverticulitis

NCT ID NCT07601958

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how 208 patients with severe diverticulitis were treated at a Brussels hospital network between 2015 and 2024. Researchers wanted to see which treatments doctors chose, such as medication alone, drainage, or different types of surgery. The goal was to understand current practices and how well they follow international guidelines.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

208 people

The number who actually took part.

Started

Dec 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients older than 18 years who were treated for acute complicated diverticulitis between January 1, 2015 and December 31, 2024 at Erasme Hospital and Institut Jules Bordet.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients presenting with a first episode or recurrence of acute complicated diverticulitis. * CT scan confirmation of a Hinchey stage ≥ Ib (including stages Ib, II, III, and IV) at admission. * Initial management performed within the HUB (Hôpital Universitaire de Bruxelles) network. * Hospital admission between January 1, 2015, and December 31, 2024. Exclusion Criteria: * Uncomplicated acute diverticulitis, defined by a CT scan Hinchey stage of 0 or Ia. * Patients in whom the diagnosis of acute diverticulitis was ultimately ruled out during medical chart review. * Patients whose initial management occurred at another hospital facility (outside the HUB network). * Incomplete medical records preventing the reliable extraction of clinical or follow-up data.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute complicated diverticulitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institut Jules Bordet

    Anderlecht, Brussels Capital, 1070, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.